Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Biohit: Preconditions for a turnaround

Biohit

Biohit is focused on diagnostics of the gastrointestinal tract and health-promoting products. The company has shown the first signs of a turnaround after a long loss-making period. We believe that the development of new products and successful commercialization are key to the company's long-term success. Analyst Antti Siltanen tells more about the company.

Read more about Biohit: https://www.inderes.se/research/biohit-sustainability-of-turnaround-being-tested

00:00 Intro
00:26 Biohit’s business
01:56 International markets
03:18 Competitive advantages
04:20 Product development
05:53 Strategy
07:18 Profitability and financial targets
08:51 Outlook
10:32 Valuation

Stay up to date
Analyst Interviews

Recent videos

Rapala H2'25: North American sales a highlight of the end of the year
2026-03-12 16:25 Rapala VMC
Columbus – Presentation of Annual Report 2025
2026-03-12 13:00 Columbus
Tokmanni Q4’25: Dollarstore’s turnaround is stalling
2026-03-12 12:02 Tokmanni Group
Multitude, Webcast, Q4'25
2026-03-12 10:00 Multitude
Rapala VMC Oyj, Audiocast, Q4'25
2026-03-12 10:00 Rapala VMC
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.